Elemental
Published in

Elemental

The Best of the Coronavirus Blog This Week

Welcome to the fall surge

The latest vaccine news. This week, Johnson & Johnson and Novavax’s Covid-19 vaccine candidates advanced to the final stages of clinical trials, which brings the number of vaccines in phase 3 trials to 11. Johnson & Johnson’s vaccine may have an advantage over its competitors because it could need only one shot instead of two and doesn’t have to be kept frozen. Read more news from the vaccine race below.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Alexandra Sifferlin

Alexandra Sifferlin

Health and science journalist. Former editor of Medium’s Covid-19 Blog and deputy editor at Elemental. TIME Magazine writer before that